Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07479433 · ClinicalTrials.gov registry record
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
A clinical trial of Coronary Artery Disease (CAD), sponsored by HeartFlow.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT07479433: Recruiting study of Coronary Artery Disease (CAD), sponsored by HeartFlow.
NCT07479433 is a study of Coronary Artery Disease (CAD) that is actively recruiting participants, run by HeartFlow. The registered enrollment target is 5,000 participants, above the 144-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (3372% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07479433, a study of Coronary Artery Disease (CAD), is actively recruiting participants, sponsored by HeartFlow.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
Primary Outcome
The primary endpoint will be assessed only in Group 2 and is a change in procedural plan following review of the information provided by PCI Navigator compared to procedural plan with angiographic imaging alone. The primary endpoint will be measured by calculating the percentage of patients in whom a change of plan was documented following review of the PCI Navigator tool compared to the plan documented prior to using the tool.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Heartflow PCI Navigator
Study Locations (1)
Georgia
- Wellstar Health System - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2032-12-31 |
What NCT07479433 shows while recruiting
NCT07479433 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 144-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (3372% higher).
The record links to 1 condition, with Coronary Artery Disease (CAD) appearing as the primary indexed condition, and to 1 intervention - of which Heartflow PCI Navigator is the first listed.
NCT07479433 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07479433 about?
NCT07479433 is a clinical study titled "The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI". The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
What is the current status of trial NCT07479433?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2026-03-11. Estimated completion is 2032-12-31.
What conditions does trial NCT07479433 study?
This clinical trial studies the following conditions: Coronary Artery Disease (CAD).
What interventions are being tested in trial NCT07479433?
The interventions under investigation include: Heartflow PCI Navigator (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07479433?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07479433 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease (CAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Beating the Blues for Your Heart
COMPLETED · Phase 2
-
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
COMPLETED
-
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
COMPLETED
-
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI